Navigation Links
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
Date:12/20/2010

, inappropriate blood vessels that can cause further vision loss and more serious complications.  Release of vascular endothelial growth factor (VEGF) contributes to increased vascular permeability in the eye and inappropriate new vessel growth.  It is believed that anti-VEGF treatment may help decrease vascular permeability and edema and prevent the inappropriate growth of new blood vessels in the retina in patients with CRVO.

About Diabetic Macular Edema (DME)DME is the most prevalent cause of moderate vision loss in patients with diabetes.  DME is a common complication of Diabetic Retinopathy (DR), a disease affecting the blood vessels of the retina.  Clinically significant DME is a leading cause of blindness in younger adults (under 50).  Clinically significant DME occurs when fluid leaks into the center of the macula, the light-sensitive part of the retina responsible for sharp, direct vision.  Fluid in the macula can cause severe vision loss or blindness.

Approximately 370,000 Americans currently suffer from clinically significant DME, with 95,000 new cases arising each year.  According to the American Diabetes Association, more than 18 million Americans currently suffer from diabetes, and many other people are at risk for developing diabetes.  With the incidence of diabetes steadily climbing, it is projected that up to 10 percent of all patients with diabetes will develop DME during their lifetime.

About VEGF Trap-EyeVEGF Trap-Eye is a fully human fusion protein, consisting of soluble VEGF receptors 1 and 2, that binds all forms of VEGF-A along with the related Placental Growth Factor (PlGF).  VEGF Trap-Eye is a specific and highly potent blocker of these growth factors.  VEGF Trap-Eye is specially purified and contains iso-osmotic buffer concentrations, allowing for injection into the eye.

Regeneron and Bayer HealthCare are collaborating on the global development of VEGF Trap
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
2. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
3. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
4. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
5. Regeneron Reports Third Quarter 2009 Financial and Operating Results
6. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
7. Regeneron Announces Presentation at the Deutsche Bank 2009 Biotech Boston Confab
8. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
9. Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference
10. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
11. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... Texas , March 30, 2015  Caris Life ... found drugs targeting specific pathways may have potentially significant ... cancer. The study results were highlighted today in an ... of Gynecologic Oncology (SGO) 2015 Annual Meeting on Women,s ... This study is one of four presented at ...
(Date:3/30/2015)... 2015 NiQ Health, "the ... the high level interface capabilities of their CarePlus™ ... The partnership between CarePlus™ and ClinicAll ... allows patients to choose the most appropriate alarm ... The advanced functionality of CarePlus™ allows patient alarms ...
(Date:3/30/2015)... 30, 2015 DURECT Corporation (Nasdaq: ... a multi-dose Phase 1 clinical trial of an ... DURECT,s Epigenomic Regulator Program.  DUR-928 is an endogenous, ... broad applicability in metabolic diseases such as nonalcoholic ...  It may also play an important role in ...
Breaking Medicine Technology:Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 2Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 3Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 4NiQ Health Announces CarePlus(TM) Integration with ClinicAll 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4
... (Nasdaq: MYL ) today commented on the death of ... Mylan Chairman and CEO Robert J. Coury said: "We ... one-of-a-kind individual. Mike was a pioneer in many ways and helped ... of us who knew Mike personally will always remember him as ...
... urging the U.S. Department of Health and Human Services ... affordable, flexible benefits in the exchanges, the Institute of ... and some powerful special interests that benefit from costly ... (PCMA). A new survey ...
Cached Medicine Technology:PCMA on IOM Essential Health Benefits Report: Employers and Special Interests Will Spar Over Costly Prescription Drug Mandates 2
(Date:3/31/2015)... Miraca Life Sciences, the nation’s largest independent anatomic ... pathology offering , to include critical testing for both ... pathology services feature:, Definitive diagnoses ... terminology and diagnostic criteria , Quantitative prognostic ... , Molecular tumor profiling , ...
(Date:3/31/2015)... TX (PRWEB) March 31, 2015 ... independent freestanding emergency rooms in the United States, announced ... April. , “I am pleased to announce that ... Worth metroplex in Haslet,” said Dr. James M. Muzzarelli, ... , First Choice Emergency Room is revolutionizing the delivery ...
(Date:3/31/2015)... Buffalo, NY (PRWEB) March 31, 2015 ... been recognized by peers across the country for distinguished ... profession. The New York State Athletic Trainers’ Association ... extend congratulations to these NYS athletic trainers - especially ... (NATM)! The Ed Block Courage Award for ...
(Date:3/30/2015)... (PRWEB) March 31, 2015 A new ... aid patients and family members who may have been ... pregnancy for morning sickness. The site was created in ... of GlaxoSmithKline in C.A. No. 11-10398-RWZ, filed with the ... Toronto Star reports that this case alleged that ...
(Date:3/30/2015)... 31, 2015 NAPW honors ... Woman of the Year. Ms. Lucht is recognized with ... largest, most-recognized networking organization of professional women in the ... Association of Professional Women is a powerfully vibrant networking ... Chapters. , “Today’s managers need to have leadership skills ...
Breaking Medicine News(10 mins):Health News:Miraca Life Sciences Formalizes and Expands Breast Pathology Business 2Health News:Miraca Life Sciences Formalizes and Expands Breast Pathology Business 3Health News:First Choice Emergency Room to Open New Facility in Haslet, Texas 2Health News:NYS Athletic Trainers' Association Congratulates Buffalo Bills Athletic Training Staff for National Award 2Health News:NYS Athletic Trainers' Association Congratulates Buffalo Bills Athletic Training Staff for National Award 3Health News:Robert Gardner Law Announces Resource Site for Patients Prescribed Zofran During Pregnancy 2Health News:National Association of Professional Women Announces Winifred K. Lucht, Patient Financial Services Manager at Marshfield Clinic, a 2015 Professional Woman of the Year 2
... June 15 (HealthDay News) -- Being depressed doesn,t reduce ... finds. University of Michigan researchers analyzed data from ... and found that patients who were depressed or depression-free ... their excess weight within one year. They also reported ...
... Regionals 1st Middle-East & Africa Osteoporosis Meeting, to ... published its scientific programme at , http://www.iofbonehealth.org/dubai-2011/programme.html ... offering awards of 1000 USD each for the top ... age. The abstract deadline is June 17, 2011; all ...
... Researchers at the University of Toronto are the ... sleep disorder that has been closely linked to Parkinson,s ... the first to establish a potential genetic link to ... because between 60 and 80 per cent of people ...
... rock stars of the rodent world, the flashiest performers of ... the ladies, a University of Florida study shows. Neotropical ... a bravura performance attracts more interest from females, according to ... Animal Behaviour by doctoral candidate Bret Pasch and colleagues ...
... An evaluation of the Public Health Grid (PHGrid) technology ... capabilities of epidemiologists and disease-control agencies when the next ... the International Journal of Grid and Utility Computing ... Centers for Disease Control and Prevention, in Atlanta, Georgia, ...
... and women who get just six hours of sleep each night ... from the cumulative effects of this mild sleep deprivation, a new ... able to cope with and recover from this kind of sleep ... the weekend after a busy workweek associated with mild sleep loss ...
Cached Medicine News:Health News:Weight-Loss Surgery Can Be Effective Despite Depression 2Health News:Program announced for 1st Middle-East & Africa Osteoporosis Meeting 2Health News:Potential cause of severe sleep disorder discovered, implications for Parkinson's disease 2Health News:UF study: When singing mice choose a mate, a skillful song gets the gal 2Health News:UF study: When singing mice choose a mate, a skillful song gets the gal 3Health News:A grid approach to pandemic disease control 2Health News:Weekend Not Long Enough to Recover From Workweek Sleep Loss 2
... two and four ounce bottles ... the needs of procedural kit ... itself has been custom molded ... the cap perfectly. This product ...
A patient skin prepping solution in a self-contained applicator combining two proven broad-spectrum antimicrobials: alcohol for fast kill and fast drying (3 minutes on skin), and an iodophor for pers...
Idophor PVP Scrub Winged Sponges...
... can be a valuable tool in standardizing ... items necessary for a procedure are supplied ... continuum of care are easier to be ... sequence of use, allowing the clinician to ...
Medicine Products: